Search

everythinglearnresearchcommunity

for

Search:↓

Leydig cell hyperplasia can cause virilization in postmenopausal women and is treatable with surgery.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

Removing one ovary helped treat a woman's severe PCOS symptoms when medicine didn't work.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Sex hormones affect liver fat and metabolic health differently in men and women.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Some women with PCOS have rare genetic variants linked to the condition.

Hirsutism in GCC countries is influenced by genetics, obesity, and lifestyle, with cultural stigma delaying treatment, highlighting the need for tailored health strategies.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Low-level laser therapy may help hair growth, but more research is needed.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.